KPT-8602 IS A SECOND-GENERATION XPO1 INHIBITOR WITH IMPROVED IN VIVO TOLERABILITY AND POTENT IN VIVO ACTIVITY AGAINST ACUTE LYMPHOBLASTIC LEUKEMIAJ. De Bie,J. Neggers, A. Dagklis,T. Vercruysse,O. Gielen,E. Baloglu,W. Senapedis,S. Shacham,Y. Landesman,A. Uyttebroeck, N. Boeckx, J. Cools,D. DaelemansHAEMATOLOGICA(2016)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要